13D Filing: James E. Flynn and Adeptus Health Inc. (ADPT)

Page 6 of 8 – SEC Filing

SCHEDULE 13D

CUSIP No.  006855100 Page 6 of 8 Pages
1

NAME OF REPORTING PERSONS

James E. Flynn

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☒

3

SEC USE ONLY

4

SOURCE OF FUNDS

AF

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States of America

 

 

 NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

1,600,861 (5)

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

1,600,861 (5)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,600,861 (5)

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.76 % (5)

14

TYPE OF REPORTING PERSON

IN

(5) Consists of shares of Class A Common Stock held by Deerfield
Partners, L.P. and Deerfield International Master Fund, L.P. James E. Flynn is the managing member of the general partner of each
of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P., the general partner and the investment adviser, respectively,
of Deerfield Partners, L.P. and Deerfield International Master Fund, L.P. The percentage of outstanding Class A Common Stock beneficially
owned has been determined based on 16,395,599 shares of Class A Common Stock outstanding as of November 7, 2016, as set forth
in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2016.

Follow Adeptus Health Inc. (NYSE:ADPT)